Drugs & Trials for Cancer Diagnostics

A User's Perspective

About this webinar

Recorded On: Wednesday, March 4, 2020

Golden Helix software solutions provide many automated services to streamline variant analysis. This is true when regarding the curation of critical annotations, automation of tertiary project processing via VSPipeline, and of course, the automation of the ACMG and AMP guidelines. Our first iteration when integrating the AMP/ASCO guidelines has added dramatic simplicity and consistency in evaluating biomarkers and provide treatment options via VSReports. Our latest release now includes the automated collection of relevant clinical trials available. In our upcoming webcast, we will be discussing the importance and values of automating the search for available clinical trials for the improvement of cancer treatment and prevention. In addition to exploring the detailed content leveraged by VSClinical for site, inclusion criteria, relevant drugs, and matching biomarkers, we will also explore multiple examples to showcase these features during the webcast.

Here are highlights of the topics to be covered:

-        Somatic guidelines inclusion of reporting on clinical trials

-        Discuss the NCI source database clinical trial content

-        Explore the automated integration of accessing clinical trial content from VSClinical

-        Review example biomarkers to demonstrate the process to report

Want more? Watch our previous webcast of this series introducing Drugs & Trials for the first time here.

Watch on demand

Please enjoy this webcast recording. Should you have any questions about the content covered, please reach out to our team here.

Download the slide deck

To download a copy of the slides, click on the LinkedIn icon. This will redirect you to the SlideShare site. From there, you can clip your favorite slides or download the entire deck to your computer.

Love this webcast? Check out more!

Find out how Golden Helix software enables users to harness the full potential of genomics to identify the cause of disease, improve the efficacy and safety of drugs, develop genomic diagnostics, and advance the quest for personalized medicine.